CIK 0000875320 · Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 043039129
- Phone
- 6173416393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,307,135
- in 1 filing, $6.3M under 10b5-1 plans
Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-04 | Ambrose Kristen SVP & Chief Accounting Officer | Grant or award | +2,566 | 10,066 | ||
| 2025-02-04 | Ambrose Kristen SVP & Chief Accounting Officer | Grant or award | +1,854 | 11,920 | ||
| 2025-02-04 | ALTSHULER DAVID EVP, Chief Scientific Officer | Grant or award | +12,314 | 38,127 | ||
| 2025-02-04 | ALTSHULER DAVID EVP, Chief Scientific Officer | Grant or award | +7,114 | 45,241 |
Page 18 of 18 · 344 trades